dr. pennell on remaining challenges in nsclc
Published 3 years ago • 119 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:22
dr. pennell on challenges with ngs in lung cancer
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
0:51
dr. pennell on the cost effectiveness of ngs in nsclc
-
29:02
sampling and evaluating lung nodules and masses: expert q&a
-
19:12
metastatic non-small cell lung cancer (nsclc) algorithm w/ targetable mutations- dr. jarushka naidoo
-
5:07
surviving with metastatic lung cancer thanks to research
-
0:59
dr. kerrigan on remaining challenges in ros1 nsclc
-
1:25
dr. kerrigan on remaining challenges in alk nsclc
-
1:34
dr. pennell on the use of brigatinib in alk nsclc
-
2:10
dr. pennell on unique treatment-related toxicities in lung cancer
-
2:11
dr. pennell on considerations for immediate treatment in lung cancer
-
1:39
dr. pennell on benefits of liquid biopsies in lung cancer
-
1:53
dr. pennell on the risks associated with sequential therapy with immunotherapy/tkis in lung cancer
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
2:26
dr. pennell on the underutilization of genetic testing in lung cancer
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
1:03
dr. herbst on combination of nivolumab and ipilimumab in patients with nsclc
-
1:02
dr. gubens discusses the role of pd-l1 in patients with nsclc
-
1:08
dr. heinzerling on remaining challenges for treating nsclc
-
1:25
dr. wolf on updated findings with capmatinib in metex14-mutant nsclc